Yicheng Chen

699 total citations
27 papers, 424 citations indexed

About

Yicheng Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yicheng Chen has authored 27 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Yicheng Chen's work include Cell death mechanisms and regulation (3 papers), Virus-based gene therapy research (2 papers) and DNA Repair Mechanisms (2 papers). Yicheng Chen is often cited by papers focused on Cell death mechanisms and regulation (3 papers), Virus-based gene therapy research (2 papers) and DNA Repair Mechanisms (2 papers). Yicheng Chen collaborates with scholars based in Taiwan, China and United States. Yicheng Chen's co-authors include Marimélia Porcionatto, Kimberley F. Tolias, Jay B. Bikoff, Michael E. Greenberg, Elizabeth J. Hong, Rosalind A. Segal, Mariecel Pilapil, Yoojin Choi, Pengcheng Zhou and Jih‐Hwa Guh and has published in prestigious journals such as Neuron, PLoS ONE and The FASEB Journal.

In The Last Decade

Yicheng Chen

27 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yicheng Chen Taiwan 12 243 82 56 54 50 27 424
Érico T. Costa Brazil 14 224 0.9× 44 0.5× 65 1.2× 60 1.1× 25 0.5× 24 391
Xiaojing Wu China 11 145 0.6× 44 0.5× 39 0.7× 36 0.7× 37 0.7× 28 339
Ran An China 13 324 1.3× 113 1.4× 31 0.6× 99 1.8× 77 1.5× 31 613
Pítia Flores Ledur Brazil 10 217 0.9× 36 0.4× 99 1.8× 61 1.1× 30 0.6× 11 441
Kyung Hwa Kang South Korea 13 380 1.6× 67 0.8× 61 1.1× 49 0.9× 14 0.3× 28 488
Muayyad R. Al-Ubaidi United States 14 354 1.5× 109 1.3× 37 0.7× 28 0.5× 30 0.6× 29 582
Tessa Grabinski United States 11 347 1.4× 66 0.8× 39 0.7× 27 0.5× 11 0.2× 15 551
Thomas Harnois France 14 365 1.5× 176 2.1× 78 1.4× 27 0.5× 27 0.5× 22 617
Nickolay V. Kukekov United States 6 258 1.1× 76 0.9× 47 0.8× 39 0.7× 14 0.3× 7 357
Keith Del Villar United States 9 246 1.0× 43 0.5× 86 1.5× 28 0.5× 28 0.6× 12 369

Countries citing papers authored by Yicheng Chen

Since Specialization
Citations

This map shows the geographic impact of Yicheng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yicheng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yicheng Chen more than expected).

Fields of papers citing papers by Yicheng Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yicheng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yicheng Chen. The network helps show where Yicheng Chen may publish in the future.

Co-authorship network of co-authors of Yicheng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yicheng Chen. A scholar is included among the top collaborators of Yicheng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yicheng Chen. Yicheng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xudong, Ying Guo, Tom Wei‐Wu Chen, et al.. (2025). Acyl post-translational modification of proteins by metabolites in cancer cells. Cell Death Discovery. 11(1). 247–247. 1 indexed citations
2.
Guo, Ying, Xudong Wang, Chen Zhang, et al.. (2025). Tumor Immunotherapy Targeting B7-H3: From Mechanisms to Clinical Applications. ImmunoTargets and Therapy. Volume 14. 291–320. 7 indexed citations
3.
Hu, Che‐Yuan, Chao‐Ching Chang, Yicheng Chen, et al.. (2024). Syngeneic mesenchymal stem cells loaded with telomerase-dependent oncolytic adenoviruses enhance anti-metastatic efficacy. Stem Cells Translational Medicine. 13(8). 738–749. 2 indexed citations
4.
Wang, Le, Yicheng Chen, Zhouyang Zhang, et al.. (2023). TiO2 nanotubes induce early mitochondrial fission in BMMSCs and promote osseointegration. Biomedical Materials. 18(2). 25008–25008. 8 indexed citations
5.
Chen, Yicheng, Fu‐Tong Liu, Michael M. C. Lai, et al.. (2023). Upregulation of galectin-3 in influenza A virus infection promotes viral RNA synthesis through its association with viral PA protein. Journal of Biomedical Science. 30(1). 14–14. 10 indexed citations
6.
Chen, Yicheng, et al.. (2022). Polypeptide Bilayer Assembly-Mediated Gene Delivery Enhances Chemotherapy in Cancer Cells. Molecular Pharmaceutics. 20(1). 680–689. 1 indexed citations
7.
Wu, Hung‐Tsung, et al.. (2022). Sucralose, a Non-nutritive Artificial Sweetener Exacerbates High Fat Diet-Induced Hepatic Steatosis Through Taste Receptor Type 1 Member 3. Frontiers in Nutrition. 9. 823723–823723. 23 indexed citations
8.
Wei, Saisai, Wenhao Guo, Qian Yu, et al.. (2021). Ribosome profiling reveals translatome remodeling in cancer cells in response to zinc oxide nanoparticles. Aging. 13(19). 23119–23132. 4 indexed citations
9.
Chiou, Yee‐Hsuan, et al.. (2021). ZnO-loaded DNA nanogels as neutrophil extracellular trap-like structures in the treatment of mouse peritonitis. Materials Science and Engineering C. 131. 112484–112484. 13 indexed citations
10.
Chen, Yicheng, Yiqing Zhao, David L. Bajor, Zhenghe Wang, & J. Eva Selfridge. (2020). A facile and sensitive method of quantifying glutaminase binding to its inhibitor CB-839 in tissues. Journal of genetics and genomics. 47(7). 389–395. 4 indexed citations
11.
Chen, Yicheng, Gia‐Shing Shieh, Pei‐Hsin Huang, et al.. (2019). Prothymosin α promotes STAT3 acetylation to induce cystogenesis in Pkd1‐deficient mice. The FASEB Journal. 33(11). 13051–13061. 4 indexed citations
12.
Chen, Yicheng, Huan Wang, Yuanlei Chen, et al.. (2019). LINC00461 affects the survival of patients with renal cell carcinoma by acting as a competing endogenous RNA for microRNA‑942. Oncology Reports. 42(5). 1924–1934. 17 indexed citations
13.
14.
Liu, Zhiqiang, et al.. (2014). Induction of Chemoresistance by All-Trans Retinoic Acid via a Noncanonical Signaling in Multiple Myeloma Cells. PLoS ONE. 9(1). e85571–e85571. 11 indexed citations
15.
Chen, Yicheng, Lu Liu, Wei Wang, et al.. (2012). C1orf61 acts as a tumor activator in human hepatocellular carcinoma and is associated with tumorigenesis and metastasis. The FASEB Journal. 27(1). 163–173. 15 indexed citations
16.
Chen, Yicheng, et al.. (2011). Discovery of Protein Phosphorylation Motifs through Exploratory Data Analysis. PLoS ONE. 6(5). e20025–e20025. 16 indexed citations
19.
Hsiao, Che‐Jen, Yunn‐Fang Ho, John T.-A. Hsu, et al.. (2008). Mana-Hox displays anticancer activity against prostate cancer cells through tubulin depolymerization and DNA damage stress. Naunyn-Schmiedeberg s Archives of Pharmacology. 378(6). 599–608. 8 indexed citations
20.
Zhou, Pengcheng, Marimélia Porcionatto, Mariecel Pilapil, et al.. (2007). Polarized Signaling Endosomes Coordinate BDNF-Induced Chemotaxis of Cerebellar Precursors. Neuron. 55(1). 53–68. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026